AWS re:Invent 2017: How Eli Lilly Leverages AWS as a Clinical Innovation Platform to (LFS306)

Опубликовано 28 ноября 2017, 18:41

The Clinical Innovation Labs team at Eli Lilly and Company is leveraging AWS services, design thinking methodology, and co-creation to transform ideas for translating clinical research into real-world solutions. The Eli Lilly “Innovators’ Platform” is a rapid prototyping environment that combines patient behavior discovery analysis, art-of-the-possible storyboarding, health device mockup creation, and simulated patient walkthrough analysis. This platform is used to demonstrate the capabilities of emerging technologies and enables participants to contribute ideas to extend the platform. This presentation describes how the team and its processes work together, what components make up the platform, and why it&rdsquo;s making an impact on patient health. We discuss the team’s use of various AWS services, including AWS Lambda, Amazon API Gateway, AWS IoT, Amazon Cognito, Amazon S3, and AWS Elastic Beanstalk. We also provide demos of what has been built using this platform methodology.